Moreover, TR may trigger adipose tissue browning throughout the induction of the AMPK-ATGL-UCP1 pathway and, subsequently, may have promise as a potential therapeutic agent for the treatment and prevention of obesity. This evidence concerns the gene PNPLA2 and obesity due to melanocortin 4 receptor deficiency.